![BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin](https://pub.mdpi-res.com/biomed/biomed-03-00015/article_deploy/html/images/biomed-03-00015-g001.png?1678450543)
BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
![Esperivit Q 100, integratore a base di esperidina, quercetina e vitamina C - Vanda Integrative Medicine Esperivit Q 100, integratore a base di esperidina, quercetina e vitamina C - Vanda Integrative Medicine](https://www.vandaomeopatici.it/it/wp-content/uploads/2020/10/Esperivit-vai-alla-scheda.jpg)
Esperivit Q 100, integratore a base di esperidina, quercetina e vitamina C - Vanda Integrative Medicine
![PDF) Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom PDF) Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom](https://i1.rgstatic.net/publication/357070345_Retrospective_Study_of_Outcomes_and_Hospitalization_Rates_of_Patients_in_Italy_with_a_Confirmed_Diagnosis_of_Early_COVID-19_and_Treated_at_Home_Within_3_Days_or_After_3_Days_of_Symptom_Onset_with_Pres/links/61fdb3cb1674b45977c56be7/largepreview.png)
PDF) Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom
![BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin](https://pub.mdpi-res.com/biomed/biomed-03-00015/article_deploy/html/images/biomed-03-00015-ag-550.jpg?1678691991)